Key Takeaways
- • Maven 11, an Amsterdam-based crypto venture capital firm, closed its third fund at $107 million, exceeding its $100 million target despite a nine-month fundraising delay and cautious institutional LP sentiment.
- • The fund received backing from existing anchor investor Theta Capital Management and new institutional capital from Europe and Asia, demonstrating sustained confidence in the firm's early-stage crypto investment thesis.
- • Maven 11's investment focus spans early-stage opportunities in consumer applications, infrastructure, and emerging AI-blockchain intersection sectors, building on prior successful bets including Celestia, GTE, Spire, Chainbound, Gensyn, Beam, and Lagrange.
- • The firm launched the Maven 11 Residency Program to support exceptional founders at the earliest stages, initially piloting with winners from the Celestia Mammothon hackathon, signaling an expanded support model beyond traditional venture capital deployment.
- • Fund III has already commenced capital deployment, positioning Maven 11 to lead more deals in the European venture landscape amid a challenging LP fundraising environment.
Summary
Maven 11 successfully closed its third venture fund at $107 million on March 27, 2025, surpassing its $100 million target despite navigating a cautious institutional investor climate. The Amsterdam-based cryptocurrency-native venture firm completed the fundraise after a nine-month extension, reflecting broader headwinds affecting crypto venture capital fundraising but ultimately securing institutional commitments from both existing and new limited partners across Europe and Asia.
The fund's anchor investor, Theta Capital Management, continued its backing alongside newly committed institutional capital, signaling sustained confidence in Maven 11's investment approach and thesis around blockchain technology adoption. This capital commitment demonstrates that selective institutional investors remain willing to deploy capital into established crypto-focused managers with demonstrated track records, even as broader LP caution persists across the sector.
Maven 11's portfolio strategy emphasizes early-stage investments with particular focus on consumer applications, infrastructure development, and the emerging intersection of artificial intelligence and blockchain technology. The firm's prior investment performance includes successful early-stage positions in projects such as Celestia, GTE, Spire, Chainbound, Gensyn, Beam, and Lagrange, providing credibility for its continued thesis and deal sourcing capabilities within the European venture ecosystem.
Beyond traditional venture capital deployment, Maven 11 announced the Maven 11 Residency Program, a new initiative designed to provide exceptional founders with initial capital, mentorship, and network integration during the earliest company-building stages. The program will pilot with selected winners from the Celestia Mammothon hackathon, reflecting the firm's commitment to expanding founder support mechanisms and capturing learnings from portfolio companies to benefit the broader ecosystem.
Fund III has already commenced capital deployment, enabling Maven 11 to lead an increased volume of deals within the European venture landscape. The firm's ability to exceed fundraising targets and rapidly begin investing suggests institutional appetite for proven crypto-focused managers positioned to support early-stage blockchain projects during a period of selective market consolidation.
The fund's anchor investor, Theta Capital Management, continued its backing alongside newly committed institutional capital, signaling sustained confidence in Maven 11's investment approach and thesis around blockchain technology adoption. This capital commitment demonstrates that selective institutional investors remain willing to deploy capital into established crypto-focused managers with demonstrated track records, even as broader LP caution persists across the sector.
Maven 11's portfolio strategy emphasizes early-stage investments with particular focus on consumer applications, infrastructure development, and the emerging intersection of artificial intelligence and blockchain technology. The firm's prior investment performance includes successful early-stage positions in projects such as Celestia, GTE, Spire, Chainbound, Gensyn, Beam, and Lagrange, providing credibility for its continued thesis and deal sourcing capabilities within the European venture ecosystem.
Beyond traditional venture capital deployment, Maven 11 announced the Maven 11 Residency Program, a new initiative designed to provide exceptional founders with initial capital, mentorship, and network integration during the earliest company-building stages. The program will pilot with selected winners from the Celestia Mammothon hackathon, reflecting the firm's commitment to expanding founder support mechanisms and capturing learnings from portfolio companies to benefit the broader ecosystem.
Fund III has already commenced capital deployment, enabling Maven 11 to lead an increased volume of deals within the European venture landscape. The firm's ability to exceed fundraising targets and rapidly begin investing suggests institutional appetite for proven crypto-focused managers positioned to support early-stage blockchain projects during a period of selective market consolidation.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.